An investigation into the origin of the biased agonism associated with the urotensin II receptor activation

The urotensin II receptor (UTR) has long been studied mainly for its involvement in the cardiovascular homeostasis both in health and disease state. Two endogenous ligands activate UTR, i.e. urotensin II (U‐II) and urotensin II‐related peptide (URP). Extensive expression of the two ligands uncovers...

Full description

Saved in:
Bibliographic Details
Published inJournal of peptide science Vol. 21; no. 5; pp. 392 - 399
Main Authors Brancaccio, Diego, Merlino, Francesco, Limatola, Antonio, Yousif, Ali Munaim, Gomez-Monterrey, Isabel, Campiglia, Pietro, Novellino, Ettore, Grieco, Paolo, Carotenuto, Alfonso
Format Journal Article
LanguageEnglish
Published England Blackwell Publishing Ltd 01.05.2015
Wiley Subscription Services, Inc
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:The urotensin II receptor (UTR) has long been studied mainly for its involvement in the cardiovascular homeostasis both in health and disease state. Two endogenous ligands activate UTR, i.e. urotensin II (U‐II) and urotensin II‐related peptide (URP). Extensive expression of the two ligands uncovers the diversified pathophysiological effects mediated by the urotensinergic system such as cardiovascular disorders, smooth muscle cell proliferation, renal disease, diabetes, and tumour growth. As newly reported, U‐II and URP have distinct effects on transcriptional activity, cell proliferation, and myocardial contractile activities supporting the idea that U‐II and URP interact with UTR in a distinct manner (biased agonism). To shed light on the origin of the divergent activities of the two endogenous ligands, we performed a conformational study on URP by solution NMR in sodium dodecyl sulfate micelle solution and compared the obtained NMR structure of URP with that of hU‐II previously determined. Finally, we undertook docking studies between URP, hU‐II, and an UT receptor model. Copyright © 2015 European Peptide Society and John Wiley & Sons, Ltd. The urotensin II receptor (UTR) has long been studied mainly for its involvement in the cardiovascular homeostosis. The endogenous ligands of UTR, U‐II, and URP can exert common as well as different actions (biased agonism). To shed light on the origin of the divergent activities of two endogenous ligands, we performed a conformational study on URP, compared the obtained NMR structure of URP with that of hU‐II previously determined, and undertook docking studies between URP, hU‐II, and a newly developed UT receptor model.
Bibliography:istex:1D34D51BEB8E1E856B6F124D84D1177EB3A74E4A
Supporting info item
ArticleID:PSC2740
Special issue of contributions presented at the 14th Naples Workshop on Bioactive Peptides "The renaissance era of peptides in drug discovery", June 12-14, 2014, Naples".
ark:/67375/WNG-XZ4C5XX0-P
ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISSN:1075-2617
1099-1387
DOI:10.1002/psc.2740